Enzastaurin 25 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin
Search Results
Enzastaurin 10 mg | 98.52%
TargetMol
Enzastaurin (LY317615) is an effective PKCβ selective inhibitor (IC50: 6 nM), 6- to 20-fold selectivity against PKCα/γ/ε.
More Information Supplier PageEnzastaurin
KU-57788 5 mg | 99.87%
TargetMol
NU7441 (KU-57788) is a highly effective and specific DNA-PK inhibitor (IC50: 14 nM).
More Information Supplier PageKU-57788
KU-57788 50 mg | 99.87%
TargetMol
NU7441 (KU-57788) is a highly effective and specific DNA-PK inhibitor (IC50: 14 nM).
More Information Supplier PageKU-57788
Mirdametinib 10 mg | 99.91%
TargetMol
PD0325901 is a specific and non-ATP-competitive MEK inhibitor (IC50: 0.33 nM).
More Information Supplier PageMirdametinib
Mirdametinib 100 mg | 99.91%
TargetMol
PD0325901 is a specific and non-ATP-competitive MEK inhibitor (IC50: 0.33 nM).
More Information Supplier PageMirdametinib
Orantinib 5 mg | 100.00%
TargetMol
TSU-68, a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.
More Information Supplier PageOrantinib
Orantinib 50 mg | 100.00%
TargetMol
TSU-68, a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.
More Information Supplier PageOrantinib
Orantinib 25 mg | 100.00%
TargetMol
TSU-68, a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.
More Information Supplier PageOrantinib
Orantinib 10 mg | 100.00%
TargetMol
TSU-68, a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR.
More Information Supplier PageOrantinib